MetaXcan drug
Evidence from:
primary |
all sources
Related entities (7)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| MetaXcan | associated_with | brain tissue | — | 1 |
| MetaXcan | interacts_with | eQTLGen Consortium | — | 1 |
| MetaXcan | associated_with | GTEx v8 | — | 1 |
| MetaXcan | interacts_with | GWAS | — | 1 |
| MetaXcan | interacts_with | S-PrediXcan | — | 1 |
| MetaXcan | associated_with | whole blood | — | 1 |
| S-MultiXcan | associated_with | MetaXcan | — | 1 |
Mentioned in (3)
Papers in which this entity is mentioned.
- Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. (2021)
- Integrating predicted transcriptome from multiple tissues improves association detection. (2019)
- Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. (2018)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| metaxcan | drug | 3 | 4 |